Corrigendum to "Ormeloxifene, a selective estrogen receptor modulator, protects against pulmonary hypertension" [Eur. J. Pharmacol. 943 (2023) 175558]

Affiliations

• ¹ Division of Pharmacology, CSIR-Central Drug Research Institute, Lucknow, 226031, India; Academy of Scientific and Innovative Research, Ghaziabad, Uttar Pradesh, 201002, India; Animal Physiology Unit, Department of Zoology, University of Ilorin, Ilorin, Nigeria.
• ² Division of Pharmacology, CSIR-Central Drug Research Institute, Lucknow, 226031, India; Academy of Scientific and Innovative Research, Ghaziabad, Uttar Pradesh, 201002, India.
• ³ Division of Pharmacology, CSIR-Central Drug Research Institute, Lucknow, 226031, India.
• ⁴ Department of Molecular Bio-Prospection, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, India.
• ⁵ Academy of Scientific and Innovative Research, Ghaziabad, Uttar Pradesh, 201002, India; Division of Endocrinology, CSIR-Central Drug Research Institute, Lucknow, 226031, India.
• ⁶ Division of Pharmacology, CSIR-Central Drug Research Institute, Lucknow, 226031, India; Academy of Scientific and Innovative Research, Ghaziabad, Uttar Pradesh, 201002, India. Electronic address: k_hanif@cdri.res.in.